Cbot Holdings Inc

Cbot — Merger or Acquisition (October 2006)

13 slides from Cbot's merger presentation, Oct 17, 2006

  1. Slide 1: Investor Presentation

    Exhibit 99.2 ™ * Investor Presentation October 17, 2006 * Name effective upon transaction closing.

  2. Slide 2: Discussion of Forward-Looking Statements

    Discussion of Forward-Looking Statements Statements in this news release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes

  3. Slide 3: Landmark Transaction

    Landmark Transaction Combination will establish the world’s largest derivatives exchange and provide significant value to CME’s and CBOT’s customers and shareholders • Solidifies combined company’s status as the premier global exchange • Expands presence in attractive derivatives Strategically marke

  4. Slide 4: Transaction Summary

    Transaction Summary Price Per Share: $151.28 per share (1) Aggregate Consideration: $8.0 billion For each CBOT share, shareholders will receive 0.3006 CME shares, or they may elect Cash with value equal to 0.3006 CME Consideration Mix: shares based on the ten-day average CME closing price ending 2 d

  5. Slide 5: CME and CBOT Shareholder Benefits

    CME and CBOT Shareholder Benefits Transaction expected to create value for shareholders of both companies Accretive Transaction Synergy Well-Positioned Opportunities in Dynamic Global Industry Substantial Benefits Platform for Significant User Product Benefits Innovation and Growth Stronger Base to

  6. Slide 6: Well-Positioned in Dynamic Global Industry

    Well-Positioned in Dynamic Global Industry Largest market capitalization among global exchange participants Market Capitalization ($ billions) Pro Forma $30 Market Capitalization $24.8 $25 $19.9 $20 $7.1 $16.0 $15 $10.0 $10 $5.4 $17.7 $9.9 $0.8 $5.0 $5.0 $5 $2.9 $4.6 $1.9 $0 CME/CBOT (1) NYX/NXT (2)

  7. Slide 7: Platform for Product Innovation and Growth

    Platform for Product Innovation and Growth Strong and broad platform with a diversified product mix CME Standalone Transaction Revenue Mix Pro Forma Commodities Foreign Exchange & Other Transaction Revenue Mix 15% 2% Commodity & Other Eurodollars 8% Foreign 44% Exchange Eurodollars 10% 29% Equities

  8. Slide 8: Stronger Base to Build Core Derivatives Business

    Stronger Base to Build Core Derivatives Business The combined company would be the leading global derivatives exchange based on trading volume, listing three of the four most actively traded futures contracts in the world 2005 2005 Futures Volume (contracts in millions) Top Futures Exchanges 1,500 1

  9. Slide 9: Significant User Benefits

    Significant User Benefits Creates operational and cost efficiencies for market users • Access to distinct products and services on an integrated platform • Broad pipeline of innovative new products and functionality • Efficiencies through integrated systems and combined open-auction trading environm

  10. Slide 10: Proven Experience Delivering Synergies

    Proven Experience Delivering Synergies • Historic CME/CBOT clearing agreement announced in April 2003 and fully operational in January 2004 • Integration executed successfully and ahead of schedule Worked with two exchanges, all 80 clearing firms and BOTCC • Substantial savings for our clearing firm

  11. Slide 11: Substantial Potential Cost Savings

    Substantial Potential Cost Savings Expected cost savings of $125+ million annually, beginning in year two post close Cost Savings Areas Administrative 35% Technology Related 50% Trading Floor / Operations 15% Total: $125+ million 11

  12. Slide 12: Potential Revenue Opportunities

    Potential Revenue Opportunities CBOT and CME combined will be well-positioned to generate incremental revenue Cross-Selling New Products • Cross-sell the distinct • Create efficiencies of spread products and product product suite to the extensions in customer base of both • Interest rate derivatives

  13. Slide 13: Strong Financial Profile

    Strong Financial Profile Expected to be accretive to earnings 12-18 months post closing LTM Pro Forma as of 6/30/2006 CME CBOT Pro Forma Pro Forma ($ Millions) Standalone Standalone All Stock All Stock Cost Savings - - $0 $125 (1) Revenue $1,026 $532 $1,490 $1,490 (2) Operating Income $584 $194 $778

CBOT Holdings — Merger or Acquisition (October 2006) on 6ix